Adam Greenbaum, MD, explains how transcatheter electrosurgery can be used to prevent left ventricular outflow tract (LVOT) obstruction using a new procedure called Septal Scoring Along the Midline Endocardium (SESAME).

Cardiologist Peter Fail, MD, discusses the idea of using shunts to form a passage that enables the left atrium to decompress at rest and during physical activity. The goal is to lower left atrial pressure in heart failure patients.

At TVT 2022, there was debate whether CT imaging is needed for preplanning LAA procedures, and several new devices in development were discussed.

Michael Mack, MD, a key pioneer in transcatheter aortic valve replacement (TAVR), explains the history of TAVR and where things are headed.

Researchers compared the new-look drug coated balloon with an uncoated balloon, publishing their findings in JACC: Cardiovascular Interventions.

Devi Nair, MD, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit.

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

One thing was clear at TVT 2022 in Chicago: TAVR's popularity over surgery is changing the way physicians think about patient care.